Funded project

Life-saving respirators

Spain

Hospitals are expanding intensive care facilities to cope with the large number of patients admitted of COVID-19. All these temporary spaces must also be equipped and need respirators.

Funded thanks to:
  • Donors
  • Total raised
    100%raised
    • bonÀrea clients 42.322€
  • Direct beneficiaries 60.000

    Those people who have naturally benefited from the project's interventions.

  • Indirect beneficiaries 140.000

    Those identifiable people who will potentially recieve an effect from the project's activities.

IGTP

Budget

  • Materials 42.322€
  • Total 42.322€
42.322€

Description

Many initiatives are emerging, led by engineers who, with the help of doctors, develop emergency respirators for intensive use in hospital ICUs and, in general, to be able to respond to complications from the coronavirus. The Germans Trias i Pujol Institute is carrying out tests on the prototypes of these respirators.

These tests are necessary before the product reaches the patients. It is part of what is called the validation process, in which various aspects are tested to adjust it and verify that it works. In parallel, the necessary steps and certifications must be made. It is an expensive process and it needs resources.

The respirators are intended to assist ventilation in the absence of conventional respirators for patients with severe respiratory problems, such as those caused by COVID-19. The devices allow a constant and objective monitoring of respiratory rate and other parameters, it provides the patient with vital support that, otherwise, they would not have.

Activities

  • Give scientific and financial support to the development of three new models of emergency respirators to treat patients affected by COVID-19. These are models that are efficient and easy to industrialize.
  • Test the prototypes to adjust them and verify that they work, validating that they are suitable for patient use.
  • Once the prototypes have passed all validations, they must be approved by the Spanish Agency of Medicines, at which time they can begin to produce and distribute throughout the country.

Who will benefit?

COVID-19 patients with severe respiratory problems will be able to have emergency breathing devices that will allow to control the respiratory rate and other parameters constant and objective monitoring of respiratory rate and other parameters, it provides the patient with vital support that, otherwise, they would not have.

Project objectives

Equip hospital intensive care facilities with respirators, which will save the lives of those patients with severe respiratory problems, such as those caused by COVID-19 in the absence of an available conventional respirator.

Updates & Links

This website uses cookies. If you continue browsing we will consider you have accepted their use . Obtain more information.